Uncovering The Implications Of EKRA On Specific Tests And Procedures In Clinical Labs

As healthcare laws and Regulations continue to evolve, it is essential for clinical labs to stay informed on current legislation that may impact their operations. One such law that has come under scrutiny in recent years is the Eliminating Kickbacks in Recovery Act (EKRA). This law was enacted to combat patient brokering and kickbacks in the healthcare industry, but its broad language has raised concerns among clinical labs. In this article, we will explore what specific tests and procedures are under scrutiny due to EKRA and how labs can ensure compliance.

The Basics of EKRA

Before delving into the specific tests and procedures that are under scrutiny, let's first understand what EKRA entails. EKRA was signed into law as part of the SUPPORT Act in October 2018. The law prohibits Healthcare Providers, including clinical labs, from soliciting or receiving kickbacks in exchange for patient referrals to treatment facilities, recovery homes, or clinical labs.

Unlike its predecessor, the Anti-Kickback Statute (AKS), which applies only to federal healthcare programs, EKRA applies to all healthcare benefit programs, both public and private. This includes Medicare, Medicaid, and commercial insurance plans. EKRA's broad scope has raised concerns among clinical labs, as the law's language could potentially criminalize routine business practices that are common in the industry.

Tests and Procedures Under Scrutiny

While EKRA's language is broad and applies to all Healthcare Providers, there are certain tests and procedures that have come under scrutiny due to the law's focus on patient referrals and kickbacks. Clinical labs that perform the following tests and procedures should be particularly vigilant in ensuring compliance with EKRA:

  1. Genetic Testing
  2. Precision medicine tests
  3. Toxicology screenings
  4. Pharmacogenomic testing
  5. Cardiac biomarker tests

These tests and procedures are often associated with high Reimbursement rates and potential for abuse, making them prime targets for scrutiny under EKRA. Clinical labs that perform these tests should take proactive steps to ensure compliance with the law and avoid any potential legal repercussions.

Ensuring Compliance with EKRA

Given the potential legal consequences of violating EKRA, it is essential for clinical labs to take proactive measures to ensure compliance with the law. Here are some steps labs can take to mitigate their risk:

Educate Staff

  1. Provide training on the requirements of EKRA
  2. Emphasize the importance of ethical business practices
  3. Designate a compliance officer to oversee EKRA compliance

Review Contracts

  1. Review all contracts with referring physicians and treatment facilities
  2. Avoid any language that could be construed as an inducement for referrals
  3. Ensure all agreements are in writing and comply with EKRA

Monitor Referral Patterns

  1. Track and analyze referral patterns to identify any potential red flags
  2. Investigate any unusual spikes in referrals for high-Reimbursement tests
  3. Implement regular audits to ensure compliance with EKRA

Consult Legal Counsel

  1. Seek guidance from legal counsel with experience in healthcare law
  2. Review contracts and business practices with legal experts to ensure compliance
  3. Stay informed on any updates or changes to EKRA that may impact lab operations

Conclusion

As EKRA continues to be enforced and scrutinized in the healthcare industry, clinical labs must take proactive steps to ensure compliance with the law. By understanding what specific tests and procedures are under scrutiny and implementing strategies to mitigate risk, labs can protect themselves from potential legal repercussions. It is essential for labs to stay informed on current legislation and seek guidance from legal experts to navigate the complexities of EKRA and other healthcare laws.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on phlebotomy practices and healthcare. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Previous
Previous

The Next Steps After Completing a Clinical Diagnostic Lab Billing Audit

Next
Next

Elements Of Workspace Design That Impact Morale And Retention In Medical Laboratories